dibutyryl cyclic-3',5'-cytidine monophosphate has been researched along with kt 5720 in 1 studies
| Studies (dibutyryl cyclic-3',5'-cytidine monophosphate) | Trials (dibutyryl cyclic-3',5'-cytidine monophosphate) | Recent Studies (post-2010) (dibutyryl cyclic-3',5'-cytidine monophosphate) | Studies (kt 5720) | Trials (kt 5720) | Recent Studies (post-2010) (kt 5720) |
|---|---|---|---|---|---|
| 72 | 0 | 18 | 382 | 1 | 63 |
| Protein | Taxonomy | dibutyryl cyclic-3',5'-cytidine monophosphate (IC50) | kt 5720 (IC50) |
|---|---|---|---|
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 1.2907 | |
| Rho-associated protein kinase 2 | Bos taurus (cattle) | 1.2907 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaike, A; Izumi, Y; Kaneko, S; Katsuki, H; Kawato, Y; Kume, T; Nakagawa, T; Niidome, T; Osakada, F; Takada-Takatori, Y | 1 |
1 other study(ies) available for dibutyryl cyclic-3',5'-cytidine monophosphate and kt 5720
| Article | Year |
|---|---|
Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype.
Topics: alpha-Methyltyrosine; Animals; Antineoplastic Agents; Butyrates; Carbazoles; Cell Differentiation; Cell Line, Tumor; Cyclic CMP; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Neuroblastoma; Norepinephrine; Phenotype; Pyrroles; Tretinoin; Tyrosine 3-Monooxygenase | 2008 |